Key facts for NCD 270.3
- Benefit category
- Incident to a physician's professional Service
- Effective date
- 04/13/2021
- Implemented 11/09/2021
- Transmittal
- Transmittal 10981
- Versions published
- 6
TL;DR
NCD 270.3 sets Medicare's national policy for blood-derived products for chronic non-healing wounds under the benefit category "Incident to a physician's professional Service", effective 04/13/2021 and implemented 11/09/2021. Effective for services performed on or after April 13, 2021, the Centers for Medicare & Medicaid Services (CMS) will cover autologous PRP for the treatment of chronic non-healing diabetic wounds under section 1862(a)(1)(A) of the Social Security Act (the Act)… It has been revised 5 times since publication and binds every Medicare Administrative Contractor nationally.
Item or service described
A. General
Wound healing is a dynamic, interactive process that involves multiple cells and proteins. There are three progressive stages of normal wound healing, and the typical wound healing duration is about 4 weeks. While cutaneous wounds are a disruption of the normal, anatomic structure and function of the skin, subcutaneous wounds involve tissue below the skin's surface. Wounds are categorized as either acute, where the normal wound healing stages are not yet completed but it is presumed they will be, resulting in orderly and timely wound repair, or chronic, where a wound has failed to progress through the normal wound healing stages and repair itself within a sufficient time period.
Platelet-rich plasma (PRP) is produced in an autologous or homologous manner. Autologous PRP is comprised of blood from the patient who will ultimately receive the PRP. Alternatively, homologous PRP is derived from blood from multiple donors.
Blood is donated by the patient and centrifuged to produce an autologous gel for treatment of chronic, nonhealing cutaneous wounds that persist for 30 days or longer and fail to properly complete the healing process. Autologous blood derived products for chronic, non-healing wounds includes both: (1) platelet derived growth factor (PDGF) products, and (2) PRP (such as AutoloGel).
The PRP is different from previous products in that it contains whole cells including white cells, red cells, plasma, platelets, fibrin, stem cells, and fibrocyte precursors.
The PRP is used by physicians in clinical settings in treating chronic, non-healing wounds, open, cutaneous wounds, soft tissue and bone. Alternatively, PDGF does not contain cells and was previously marketed as a product to be used by patients at home.
Indications and limitations of coverage
B. Nationally Covered Indications
Effective for services performed on or after April 13, 2021, the Centers for Medicare & Medicaid Services (CMS) will cover autologous PRP for the treatment of chronic non-healing diabetic wounds under section 1862(a)(1)(A) of the Social Security Act (the Act) for a duration of 20 weeks, when prepared by devices whose Food and Drug Administration-cleared indications include the management of exuding cutaneous wounds, such as diabetic ulcers.
C. Nationally Non-Covered Indications
Autologous PDGF for the treatment of chronic, non-healing cutaneous wounds, and,
Becaplermin, a non-autologous growth factor for chronic, non-healing subcutaneous wounds, and,
Autologous PRP for the treatment of acute surgical wounds when the autologous PRP is applied directly to the closed incision, or for dehiscent wounds.
D. Other
Effective for services performed on or after April 13, 2021:
Coverage of autologous PRP for the treatment of chronic non-healing diabetic wounds beyond 20 weeks will be determined by the local Medicare Administrative Contractors (MACs).
Coverage of autologous PRP for the treatment of all other chronic non-healing wounds will be determined by the local MACs under section 1862(a)(1)(A) of the Act.
(This NCD last reviewed April 2021.)
Text reproduced from the CMS Medicare Coverage Database record for NCD 270.3 version 6. View the original on cms.gov.
Local policies that build on this NCD
13 active Local Coverage Determinations cite NCD 270.3 among their related national policies. An LCD may not conflict with the national determination; read it for the contractor's documentation and coding detail in that jurisdiction.
- Application of Bioengineered Skin Substitutes to Lower Extremity Chronic Non-Healing Wounds (L35041) · Novitas Solutions, Inc.
- LCD L36690: Wound Application of Cellular and/or Tissue Based Products (CTPs), Lower Extremities · CGS Administrators, LLC
- Wound Care, LCD L37228 · Wisconsin Physicians Service Insurance Corporation
- Wound and Ulcer Care (L38902) · Noridian Healthcare Solutions, LLC
- L35125 Wound Care · Novitas Solutions, Inc.
- L37166 Wound Care · First Coast Service Options, Inc.
- L38745 Platelet Rich Plasma · Palmetto GBA
- L38937 Platelet Rich Plasma · Wellpoint Federal
- L39023 Platelet Rich Plasma Injections for Non-Wound Injections · CGS Administrators, LLC
- L39058 Platelet Rich Plasma Injections for Non-Wound Injections · Noridian Healthcare Solutions, LLC
- L39068 Platelet Rich Plasma · Novitas Solutions, Inc.
- L39071 Platelet Rich Plasma · First Coast Service Options, Inc.
- L39575 Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound · CGS Administrators, LLC
How MACs bill NCD 270.3
A National Coverage Determination states the policy; the Medicare Administrative Contractors publish the articles that turn it into claim edits. 9 current articles in the Medicare Coverage Database name NCD 270.3, 3 of them with a covered ICD-10-CM list, from 6 contractors. The lists can differ by contractor even though the NCD is national, because each MAC codes the policy for its own claims system; check the article of the contractor that processes the claim.
| Contractor | Articles |
|---|---|
| CGS Administrators, LLC | A57311 |
| First Coast Service Options, Inc. | A57680, A58810 |
| Noridian Healthcare Solutions, LLC | A58565, A58788 |
| Novitas Solutions, Inc. | A54117, A58808 |
| Wellpoint Federal | A58609 |
| Wisconsin Physicians Service Insurance Corporation | A55909 |
A54117: Billing and Coding: Application of Bioengineered Skin Substitutes to Lower Extremity Chronic Non-Healing Wounds
Billing and Coding, effective 2026-01-01 · Novitas Solutions, Inc. (04111, 04112, 04211, 04212, 04311, 04312, 04411, 04412, 04911, 07101, 07102, 07201, 07202, 07301, 07302, 12101, 12102, 12201, 12202, 12301, 12302, 12401, 12402, 12501, 12502, 12901) · CMS record
No covered diagnosis list; 14 procedure codes: 15002, 15003, 15004, 15005, 15040, 15050, 15271, 15272, 15273, 15274, 15275, 15276 and 2 more. Local policy: L35041 Application of Bioengineered Skin Substitutes to Lower Extremity Chronic Non-Healing Wounds. Check a diagnosis for 15002.
A55909: Billing and Coding: Wound Care
Billing and Coding, effective 2026-10-01 · Wisconsin Physicians Service Insurance Corporation (05101, 05102, 05201, 05202, 05301, 05302, 05401, 05402, 05901, 08101, 08102, 08201, 08202) · CMS record
1,362 covered ICD-10-CM codes; 21 procedure codes: 11000, 11001, 11004, 11005, 11006, 11042, 11043, 11044, 11045, 11046, 11047, 97597 and 9 more. Local policy: L37228 Wound Care. Check a diagnosis for 11000.
First covered codes: A48.0 Gas gangrene; B78.1 Cutaneous strongyloidiasis; E08.51 Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy without gangrene; E08.52 Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy with gangrene; E08.621 Diabetes mellitus due to underlying condition with foot ulcer; E08.622 Diabetes mellitus due to underlying condition with other skin ulcer; …
A57311: Billing and Coding: Physical Therapy - Home Health
Billing and Coding, effective 2026-08-06 · CGS Administrators, LLC (15004) · CMS record
14,836 covered ICD-10-CM codes; 50 procedure codes: 95851, 95852, 97010, 97012, 97016, 97018, 97022, 97024, 97026, 97028, 97032, 97033 and 38 more. Local policy: L33942 Physical Therapy - Home Health. Check a diagnosis for 95851.
First covered codes: B91 Sequelae of poliomyelitis; E08.44 Diabetes mellitus due to underlying condition with diabetic amyotrophy; E08.52 Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy with gangrene; E09.44 Drug or chemical induced diabetes mellitus with neurological complications with diabetic amyotrophy; E09.52 Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy with gangrene; E10.44 Type 1 diabetes mellitus with diabetic amyotrophy; …
A57680: Billing and Coding: Application of Skin Substitute Grafts for Treatment of DFU and VLU of Lower Extremities
Billing and Coding, effective 2026-01-01 · First Coast Service Options, Inc. (09101, 09102, 09201, 09202, 09302) · CMS record
No covered diagnosis list; 8 procedure codes: 15271, 15272, 15273, 15274, 15275, 15276, 15277, 15278. Local policy: L36377 Application of Skin Substitute Grafts for Treatment of DFU and VLU of Lower Extremities. Check a diagnosis for 15271.
A58565: Billing and Coding: Wound and Ulcer Care
Billing and Coding, effective 2026-10-01 · Noridian Healthcare Solutions, LLC (01111, 01112, 01182, 01211, 01212, 01311, 01312, 01911, 02101, 02102, 02201, 02202, 02301, 02302, 02401, 02402, 03101, 03102, 03201, 03202, 03301, 03302, 03401, 03402, 03501, 03502, 03601, 03602) · CMS record
1,248 covered ICD-10-CM codes in 3 groups; 29 procedure codes: 11000, 11001, 11004, 11005, 11006, 11008, 11010, 11011, 11012, 11042, 11043, 11044 and 17 more. Local policy: L38902 Wound and Ulcer Care. Check a diagnosis for 11000.
First covered codes: E10.620 Type 1 diabetes mellitus with diabetic dermatitis; E10.621 Type 1 diabetes mellitus with foot ulcer; E10.622 Type 1 diabetes mellitus with other skin ulcer; E10.628 Type 1 diabetes mellitus with other skin complications; E10.65 Type 1 diabetes mellitus with hyperglycemia; E10.69 Type 1 diabetes mellitus with other specified complication; …
A58609: Billing and Coding: Platelet Rich Plasma
Billing and Coding, effective 2026-04-01 · Wellpoint Federal (06101, 06102, 06201, 06202, 06301, 06302, 13101, 13102, 13201, 13202, 13282, 13292, 14111, 14112, 14211, 14212, 14311, 14312, 14411, 14412, 14511, 14512) · CMS record
No covered diagnosis list; 4 procedure codes: 0232T, 0481T, M0076, P9020. Local policy: L38937 Platelet Rich Plasma. Check a diagnosis for 0232T.
A58788: Billing and Coding: Platelet Rich Plasma Injections for Non-Wound Injections
Billing and Coding, effective 2025-09-11 · Noridian Healthcare Solutions, LLC (01111, 01112, 01182, 01211, 01212, 01311, 01312, 01911, 02101, 02102, 02201, 02202, 02301, 02302, 02401, 02402, 03101, 03102, 03201, 03202, 03301, 03302, 03401, 03402, 03501, 03502, 03601, 03602) · CMS record
No covered diagnosis list; 6 procedure codes: 0232T, 86965, G0460, G0465, M0076, P9020. Local policy: L39058 Platelet Rich Plasma Injections for Non-Wound Injections. Check a diagnosis for 0232T.
A58808: Billing and Coding: Platelet Rich Plasma
Billing and Coding, effective 2023-07-01 · Novitas Solutions, Inc. (04111, 04112, 04211, 04212, 04311, 04312, 04411, 04412, 04911, 07101, 07102, 07201, 07202, 07301, 07302, 12101, 12102, 12201, 12202, 12301, 12302, 12401, 12402, 12501, 12502, 12901) · CMS record
No covered diagnosis list; 6 procedure codes: 0232T, 0481T, G0460, M0076, P9020, S9055. Local policy: L39068 Platelet Rich Plasma. Check a diagnosis for 0232T.
A58810: Billing and Coding: Platelet Rich Plasma
Billing and Coding, effective 2023-07-01 · First Coast Service Options, Inc. (09101, 09102, 09201, 09202, 09302) · CMS record
No covered diagnosis list; 6 procedure codes: 0232T, 0481T, G0460, M0076, P9020, S9055. Local policy: L39071 Platelet Rich Plasma. Check a diagnosis for 0232T.
Coverage analysis history
CMS opens a national coverage analysis (NCA) to create or reconsider an NCD; the analysis carries a CAG tracking number, the evidence review and the decision memo. The Medicare Coverage Database links 5 analyses to NCD 270.3, listed here in the order CMS opened them (by NCA record number). A reconsideration ("Recon") revisits an earlier decision; an analysis whose status is open is still in progress.
- CAG-00190N Autologous Blood-Derived Products for Chronic Non-Healing Wounds (New, Closed)
- CAG-00190R Non-Autologous Blood Derived Products for Chronic Non-Healing Wounds (1st Recon, Closed)
- CAG-00190R2 Autologous Blood Derived Products for Chronic Non-Healing Wounds (2nd Recon, Closed)
- CAG-00190R3 Autologous Blood-Derived Products for Chronic Non-Healing Wounds (3rd Recon, Closed)
- CAG-00190R4 Autologous Blood-Derived Products for Chronic Non-Healing Wounds (4th Recon, Closed)
Revision history
08/2026 - The purpose of this Change Request (CR) is to provide a quarterly maintenance update of ICD-10 coding conversions and other coding updates specific to National Coverage Determinations (NCDs). No policy is being changed as a result of these updates. ( TN 13906 ) (CR14537)
09/2025 - Transmittal 13383 issued August 26, 2025, is being rescinded and replaced by Transmittal 13401,
dated September 9, 2025, to add a new attachment to ensure the functionality of the NCD zip URL is working properly and to update the Policy section. All other information remains the same.
The purpose of this Change Request (CR) is to provide a quarterly maintenance update of ICD-10 coding conversions and other coding updates specific to National Coverage Determinations (NCDs). ( TN 13401 ) (CR14194)
10/2024 - The purpose of the Change Request (CR) is to provide a quarterly maintenance update of ICD-10 coding conversions and other coding updates specific to National Coverage Determinations(NCDs). No policy is being changed as a result of these updates. ( TN 12904 ) (CR13828)
06/2022 - Transmittal 11400, dated May 4, 2022, is being rescinded and replaced by Transmittal 11460, dated, June 17, 2022, to update NCD 90.2, NGS, spreadsheet to conform with changes in CR 12124, and change the implementation date for all business requirements except 12705.6 to 30 days from issuance of this correction. All other information remains the same.( TN 11460 ) (CR12705)
05/2022 - This Change Request (CR) constitutes a maintenance update of ICD-10 conversions and other coding updates specific to NCDs. These NCD coding changes are the result of newly available codes, coding revisions to NCDs released separately, or coding feedback received. ( TN 11400 ) (CR12705)
04/2022 - Transmittal 11262, dated February 10, 2022, is being rescinded and replaced by Transmittal 11364, dated, April 27, 2022, to include new business requirement 2611.6 for new CWF requirements to FISS. All other information remains the same.( TN 11364 ) (CR12611)
02/2022 - Transmittal 11262, dated February 10, 2022, is to inform contractors of the CWF frequency editing for the NCD 270.3 Blood-Derived Products for Chronic, Non-Healing Wounds. ( TN 11262 ) (CR12611)
01/2022 - Transmittal 11171, dated January 12, 2022, is being rescinded and replaced by Transmittal 11214, dated, January 20, 2022 to provide clarification to the note in the Claims Processing business instructions, Pub.100-04, business requirement 12403.04-01 and to update the title for the NCD 270.3 Blood Derived Products for Chronic Non-healing Wounds attachment. This correction does not make any revisions to the companion publication 100-03; all revisions are associated with publication 100-04. All other information remains the same. ( TN 11214 ) (CR12403)
01/2022 - Transmittal 11119, dated September 10, 2021, is being rescinded and replaced by Transmittal 11171, dated, January 12, 2022 to add HCPCS code G0465 to the instructions and to include additional information on HCPCS code G0460. This correction modifies the IOM attachment for publication 100-04, it also updates the background section for publication 100-04, and business requirements 12403 - 04.1 through 12403 - 04.2.2 and 12403 - 04.3 through 12403 - 04.6. This correction does not make any revisions to the companion publication 100-03; all revisions are associated with publication 100-04. All other information remains the same. ( TN 11171 ) (CR12403)
11/2021 - Transmittal 10981, dated September 8, 2021, is being rescinded and replaced by Transmittal 11119, dated, November 10, 2021 to: (1) change Business Requirements (BRs) 12403 - 04.2, BR 12403 - 04.2.1 and BR 12403 - 04.2.2 to deny, (2) revise BR 12403 - 04.4.2.2 messaging, (3) add BR 12403 - 04.2.2.1 (4) remove Part A from BR 12403 - 04.3 and BR 12403 - 04.3.1, (5) revise verbiage in BR 12403 - 04.5, and extends the implementation date. This correction does not make any revisions to the companion publication 100-03; all revisions are associated with publication 100-04. All other information remains the same. ( TN 11119 ) (CR12403)
09/2021 - The purpose of this change request is to inform MACs that effective April 13, 2021, CMS will cover autologous Platelet-Rich Plasma (PRP) for the treatment of chronic non-healing diabetic wounds under specific conditions. ( TN 10981 ) (CR12403)
11/2018 - This Change Request (CR) constitutes a maintenance update of ICD-10 conversions and other coding updates specific to NCDs. These NCD coding changes are the result of newly available codes, coding revisions to NCDs released separately, or coding feedback received.
Previous NCD coding changes appear in ICD-10 quarterly updates that can be found at: https://www.cms.gov/Medicare/Coverage/CoverageGenInfo/ICD10.html , along with other CRs implementing new policy NCDs. Edits to ICD-10 and other coding updates specific to NCDs will be included in subsequent quarterly releases and individual CRs as appropriate. No policy-related changes are included with the ICD-10 quarterly updates. Any policy-related changes to NCDs continue to be implemented via the current, long-standing NCD process.( TN 2200 ) (CR10859)
09/2018 - This Change Request (CR) constitutes a maintenance update of ICD-10 conversions and other coding updates specific to NCDs. These NCD coding changes are the result of newly available codes, coding revisions to NCDs released separately, or coding feedback received.
Previous NCD coding changes appear in ICD-10 quarterly updates that can be found at https://www.cms.gov/Medicare/Coverage/CoverageGenInfo/ICD10.html , along with other CRs implementing new policy NCDs. Edits to ICD-10 and other coding updates specific to NCDs will be included in subsequent quarterly releases and individual CRs as appropriate. No policy-related changes are included with the ICD-10 quarterly updates. Any policy-related changes to NCDs continue to be implemented via the current, long-standing NCD process.( TN 2138 ) (CR10859)
08/2018 - This Change Request (CR) constitutes a maintenance update of ICD-10 conversions and other coding updates specific to NCDs. These NCD coding changes are the result of newly available codes, coding revisions to NCDs released separately, or coding to feedback received.
Previous NCD coding changes appear in ICD-10 quarterly updates that can be found at: https://www.cms.gov/Medicare/Coverage/CoverageGenInfo/ICD10.html , along with other CRs implementing new policy NCDs. Edits to ICD-10 and other coding updates specific to NCDs will be included in subsequent quarterly releases and individual CRs as appropriate. No policy-related changes are included with the ICD-10 quarterly updates. Any policy-related changes to NCDs continue to be implemented via the current, long-standing NCD process. ( TN 2122 ) (CR10859)
01/2018 - This Change Request (CR) constitutes a maintenance update of International Code of Diseases, Tenth Revision (ICD-10)
How this NCD shows up on remittances
A service denied under a National Coverage Determination returns CARC 50 (not deemed medically necessary) with remark N386 (decision based on an NCD); a denial citing a local policy instead carries N115. Because NCDs bind nationally, the appeal path is documentation that the patient meets the indications above, not a contractor-policy argument.
For teams evaluating QuickIntell software
Evaluate a coverage-review workflow around NCD 270.3
Explore QuickAuth for requirement checks, documentation preparation and status tracking with staff oversight. Bring the policy-review steps your team repeats to a scoped evaluation, and confirm plan-specific requirements and supported actions. Use QuickRCM to evaluate the separate claim and denial workflow; a published NCD is not an authorization or payment guarantee.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
Frequently asked questions — NCD 270.3
What does NCD 270.3 cover?
Effective for services performed on or after April 13, 2021, the Centers for Medicare & Medicaid Services (CMS) will cover autologous PRP for the treatment of chronic non-healing diabetic wounds under section 1862(a)(1)(A) of the Social Security Act (the Act) for a duration of 20 weeks, when prepared by devices whose Food and Drug Administration-cleared indications include the management of exuding cutaneous wounds… The full indications and limitations are reproduced on this page from the CMS Medicare Coverage Database.
When did NCD 270.3 take effect?
The current version (6) is effective 04/13/2021, implemented 11/09/2021, published in transmittal 10981. CMS lists 6 versions of this NCD.
Does a Local Coverage Determination override NCD 270.3?
No. A National Coverage Determination binds all Medicare Administrative Contractors; an LCD can only address services or circumstances the NCD leaves open. Claims denied under this NCD typically return CARC 50 with remark N386 (NCD) rather than N115 (LCD).
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- Medicare Coverage Database NCDs via the CMS Coverage APIVersion API snapshot 2026-09-27 · effective 2026-09-20 · file national-coverage-ncd.jsonSHA-256 a90fadfd264b9ef4…
- Medicare Coverage Database, current Billing and Coding Articles exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file article.csvSHA-256 b475751458564786…
- Medicare Coverage Database national coverage analyses (NCA/CAL report) via the CMS Coverage APIVersion API snapshot 2026-11-16 · effective 2026-11-16 · file national-coverage-ncacal.jsonSHA-256 563369a07b95140a…
Disclaimer
This page reproduces the CMS National Coverage Determination text and, for laboratory NCDs, the CMS ICD-10 edit lists, as an operational reference. Coverage decisions depend on the full policy, the claim and the contractor; nothing here is legal, clinical or billing advice. CPT codes are shown as numbers only; CPT descriptors are copyright AMA.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.